What is the difference between Olanzapine And Samidorphan L-Malate and Risperidone?

Olanzapine And Samidorphan L-Malate and Risperidone are both Atypical Antipsychotics, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Can Olanzapine And Samidorphan L-Malate and Risperidone be used for the same conditions?

Both medications are prescribed for overlapping indications including an atypical antipsychotic and and samidorphan. Always verify with your prescriber and the current FDA label before switching.

Is Olanzapine And Samidorphan L-Malate the same as Risperidone?

No. Olanzapine And Samidorphan L-Malate (Olanzapine And Samidorphan L-Malate) and Risperidone (Risperidone) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Can I switch from Olanzapine And Samidorphan L-Malate to Risperidone?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

Olanzapine And Samidorphan L-Malate vs Risperidone

Compare Olanzapine And Samidorphan L-Malate (Atypical Antipsychotic) and Risperidone (Risperidone), clinical data, side effects, and patient experiences.

Olanzapine And Samidorphan L-Malate

· Atypical Antipsychotic

How it works

12.1 Mechanism of Action The mechanism of action of olanzapine is unclear; however, its efficacy in the treatment of schizophrenia or bipolar I disorder could be mediated through a...

Approved for

an atypical antipsychotic

and samidorphan

an opioid antagonist

OralTablet

Risperidone

Risperidone, Risperdal · Atypical Antipsychotic

How it works

12.1 Mechanism of Action The mechanism of action of risperidone in schizophrenia is unclear. The drug's therapeutic activity in schizophrenia could be mediated through a combinatio...

Approved for

1 INDICATIONS AND USAGE Risperidone tablets are an atypical antipsychotic indicated for: Treatment of schizophrenia ( 1.1 ) As monotherapy or adjunctive therapy with lithium or valproate

2 short-term trials in adolescents (ages 13 to 17 years)

including symptoms of aggression towards others

deliberate self-injuriousness

OralTablet

Quick Comparison

Olanzapine And Samidorphan L-MalateRisperidone

Drug Class

Atypical Antipsychotic

Route

Oral

Half-Life

N/A

FDA Approved

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Olanzapine And Samidorphan L-Malate

Drug Not Working

>10%

Weight Gain

>10%

Drowsiness

1-10%

Nausea

1-10%

Fatigue

1-10%

Anxiety

1-10%

Vomiting

1-10%

Condition Worsened

0.1-1%

Risperidone

Weight Gain

1-10%

Drug Not Working

1-10%

Drowsiness

0.1-1%

FDA Warnings

Olanzapine And Samidorphan L-Malate

5 WARNINGS AND PRECAUTIONS Cerebrovascular Adverse Reactions in Elderly Patients with Dementia-Related Psychosis : Increased incidence of cerebrovascular adverse reactions (e
, stroke, transient ischemic attack, including fatalities)
3 ) Vulnerability to Life-Threatening Opioid Overdose : Risk of Opioid Overdose from Attempts to Overcome LYBALVI Opioid Blockade: Attempts to overcome LYBALVI opioid blockade with high or repeated doses of opioids may lead to fatal opioid intoxication, particularly if LYBALVI therapy is interrupted or discontinued
4 ) Risk of Resuming Opioids in Patients with Prior Opioid Use : Patients with a history of chronic opioid use prior to LYBALVI treatment may have decreased opioid tolerance if LYBALVI therapy is interrupted or discontinued

Risperidone

5 WARNINGS AND PRECAUTIONS Cerebrovascular events, including stroke, in elderly patients with dementia-related psychosis: Risperidone tablets are not approved for use in patients with dementia-related psychosis ( 5
4 ) Metabolic Changes: Atypical antipsychotic drugs have been associated with metabolic changes that may increase cardiovascular / cerebrovascular risk
Monitor glucose regularly in patients with diabetes or at risk for diabetes
6 ) Orthostatic hypotension: For patients at risk, consider a lower starting dose and slower titration

Clinical Trial Data

No head-to-head clinical studies found for Olanzapine And Samidorphan L-Malate vs Risperidone.

Olanzapine And Samidorphan L-Malate vs Risperidone: What You Should Know

Key Differences

Both Olanzapine And Samidorphan L-Malate and Risperidone belong to the Atypical Antipsychotic class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

Olanzapine And Samidorphan L-Malate carries 4 FDA warnings. Risperidone carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Olanzapine vs Risperidone→Olanzapine vs Olanzapine And Samidorphan L-Malate→Paliperidone vs Risperidone→Olanzapine And Samidorphan L-Malate vs Paliperidone→Aripiprazole vs Risperidone→Aripiprazole vs Olanzapine And Samidorphan L-Malate→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Olanzapine And Samidorphan L-Malate: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Risperidone: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

Olanzapine And Samidorphan L-Malate vs Risperidone

Compare Olanzapine And Samidorphan L-Malate (Atypical Antipsychotic) and Risperidone (Risperidone), clinical data, side effects, and patient experiences.

Olanzapine And Samidorphan L-Malate

· Atypical Antipsychotic

How it works

12.1 Mechanism of Action The mechanism of action of olanzapine is unclear; however, its efficacy in the treatment of schizophrenia or bipolar I disorder could be mediated through a...

Approved for

an atypical antipsychotic

and samidorphan

an opioid antagonist

OralTablet

Risperidone

Risperidone, Risperdal · Atypical Antipsychotic

How it works

12.1 Mechanism of Action The mechanism of action of risperidone in schizophrenia is unclear. The drug's therapeutic activity in schizophrenia could be mediated through a combinatio...

Approved for

1 INDICATIONS AND USAGE Risperidone tablets are an atypical antipsychotic indicated for: Treatment of schizophrenia ( 1.1 ) As monotherapy or adjunctive therapy with lithium or valproate

2 short-term trials in adolescents (ages 13 to 17 years)

including symptoms of aggression towards others

deliberate self-injuriousness

OralTablet

Quick Comparison

Olanzapine And Samidorphan L-MalateRisperidone

Drug Class

Atypical Antipsychotic

Route

Oral

Half-Life

N/A

FDA Approved

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Olanzapine And Samidorphan L-Malate

Drug Not Working

>10%

Weight Gain

>10%

Drowsiness

1-10%

Nausea

1-10%

Fatigue

1-10%

Anxiety

1-10%

Vomiting

1-10%

Condition Worsened

0.1-1%

Risperidone

Weight Gain

1-10%

Drug Not Working

1-10%

Drowsiness

0.1-1%

FDA Warnings

Olanzapine And Samidorphan L-Malate

5 WARNINGS AND PRECAUTIONS Cerebrovascular Adverse Reactions in Elderly Patients with Dementia-Related Psychosis : Increased incidence of cerebrovascular adverse reactions (e
, stroke, transient ischemic attack, including fatalities)
3 ) Vulnerability to Life-Threatening Opioid Overdose : Risk of Opioid Overdose from Attempts to Overcome LYBALVI Opioid Blockade: Attempts to overcome LYBALVI opioid blockade with high or repeated doses of opioids may lead to fatal opioid intoxication, particularly if LYBALVI therapy is interrupted or discontinued
4 ) Risk of Resuming Opioids in Patients with Prior Opioid Use : Patients with a history of chronic opioid use prior to LYBALVI treatment may have decreased opioid tolerance if LYBALVI therapy is interrupted or discontinued

Risperidone

5 WARNINGS AND PRECAUTIONS Cerebrovascular events, including stroke, in elderly patients with dementia-related psychosis: Risperidone tablets are not approved for use in patients with dementia-related psychosis ( 5
4 ) Metabolic Changes: Atypical antipsychotic drugs have been associated with metabolic changes that may increase cardiovascular / cerebrovascular risk
Monitor glucose regularly in patients with diabetes or at risk for diabetes
6 ) Orthostatic hypotension: For patients at risk, consider a lower starting dose and slower titration

Clinical Trial Data

No head-to-head clinical studies found for Olanzapine And Samidorphan L-Malate vs Risperidone.

Olanzapine And Samidorphan L-Malate vs Risperidone: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Olanzapine And Samidorphan L-Malate: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Risperidone: DailyMed label · FAERS adverse events · ClinicalTrials.gov